Funding
MALARIA
The study was supported by a grant from the Bill & Melinda Gates Foundation to Pilgrim Africa (OPP1148566). This study also received financial support from US-based Rotary clubs, The Rotary Foundation and Malaria Partners International through a Rotary Global Grant (GG1423515) for which Pilgrim Africa was the implementing organization. Pirimiphos-methyl (Actellic) was purchased at a reduced price from Sigma-Tau made possible by Pilgrim Africa’s inclusion in IVCC’s subsidy agreement with next generation IRS providers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.